View in EDS

Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia.

Saved in:
Bibliographic Details
Title: Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia.
Authors: Hantel A; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Center for Bioethics, Harvard Medical School, Boston, MA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA. andrew_hantel@dfci.harvard.edu., Luskin MR; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Khan I; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Warner E; Center for Bioethics, Harvard Medical School, Boston, MA., Patel AA; Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Walsh TP; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., DeAngelo DJ; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Lathan CS; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Abel GA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Center for Bioethics, Harvard Medical School, Boston, MA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA.
Source: Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1046-1052. Date of Electronic Publication: 2024 Apr 01.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37560812
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hantel+A%22">Hantel A</searchLink>; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Center for Bioethics, Harvard Medical School, Boston, MA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA. andrew_hantel@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Luskin+MR%22">Luskin MR</searchLink>; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Khan+I%22">Khan I</searchLink>; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Warner+E%22">Warner E</searchLink>; Center for Bioethics, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Patel+AA%22">Patel AA</searchLink>; Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Walsh+TP%22">Walsh TP</searchLink>; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22DeAngelo+DJ%22">DeAngelo DJ</searchLink>; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lathan+CS%22">Lathan CS</searchLink>; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Abel+GA%22">Abel GA</searchLink>; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA; Center for Bioethics, Harvard Medical School, Boston, MA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1046-1052. <i>Date of Electronic Publication: </i>2024 Apr 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37560812
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2023.283723
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1046
    Titles:
      – TitleFull: Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hantel A
      – PersonEntity:
          Name:
            NameFull: Luskin MR
      – PersonEntity:
          Name:
            NameFull: Khan I
      – PersonEntity:
          Name:
            NameFull: Warner E
      – PersonEntity:
          Name:
            NameFull: Patel AA
      – PersonEntity:
          Name:
            NameFull: Walsh TP
      – PersonEntity:
          Name:
            NameFull: DeAngelo DJ
      – PersonEntity:
          Name:
            NameFull: Lathan CS
      – PersonEntity:
          Name:
            NameFull: Abel GA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 109
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1